Moderna, Inc. β NASDAQ:MRNA
Founder-led company
Moderna stock price today
$27.75
-12.38
-30.85%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Moderna stock price monthly change
-66.96%
month
Moderna stock price quarterly change
-66.96%
quarter
Moderna stock price yearly change
-60.16%
year
Moderna key metrics
Market Cap | 15.30B |
Enterprise value | 57.76B |
P/E | 7.77 |
EV/Sales | 3.06 |
EV/EBITDA | 5.80 |
Price/Sales | 3.16 |
Price/Book | 3.12 |
PEG ratio | -0.26 |
EPS | -15.66 |
Revenue | 5.15B |
EBITDA | -4.46B |
Income | -5.96B |
Revenue Q/Q | -91.03% |
Revenue Y/Y | -65.00% |
Profit margin | 44.3% |
Oper. margin | 49.91% |
Gross margin | 71.31% |
EBIT margin | 49.91% |
EBITDA margin | -86.67% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want toΒ keep trackΒ of and getΒ notified inΒ theΒ smart feed every time fresh news arrives.
Sign up for freeModerna stock price history
Moderna stock forecast
Moderna financial statements
Average Price Target
$103.87
Potential upside: 274.29%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 344M | -1.38B | -401.16% |
|---|---|---|---|
| Sep 2023 | 1.83B | -3.63B | -198.25% |
| Dec 2023 | 2.81B | 217M | 7.71% |
| Mar 2024 | 167M | -1.17B | -703.59% |
| Jun 2023 | 21884000000 | 4.93B | 22.55% |
|---|---|---|---|
| Sep 2023 | 19450000000 | 5.99B | 30.82% |
| Dec 2023 | 18426000000 | 4.57B | 24.81% |
| Mar 2024 | 16729000000 | 3.91B | 23.38% |
| Jun 2023 | -915M | 1.94B | -668M |
|---|---|---|---|
| Sep 2023 | -1.6B | 789M | -58M |
| Dec 2023 | 622M | -538M | -109M |
| Mar 2024 | -989M | 118M | 14M |
Moderna alternative data
Covid 19 Vaccine
| 21 May 2023 | 2 |
|---|---|
| 28 May 2023 | 0 |
| 4 Jun 2023 | 0 |
| 11 Jun 2023 | 0 |
| 18 Jun 2023 | 2 |
| 25 Jun 2023 | 3 |
| 2 Jul 2023 | 0 |
| 9 Jul 2023 | 3 |
| 16 Jul 2023 | 2 |
| 23 Jul 2023 | 0 |
| 30 Jul 2023 | 5 |
| 6 Aug 2023 | 2 |
| 13 Aug 2023 | 3 |
| 20 Aug 2023 | 2 |
| 27 Aug 2023 | 3 |
| 3 Sep 2023 | 3 |
| 10 Sep 2023 | 3 |
| 17 Sep 2023 | 5 |
| 24 Sep 2023 | 5 |
| 1 Oct 2023 | 8 |
Covid-19 Vaccine
| 21 May 2023 | 7 | 5 | 0 |
|---|---|---|---|
| 28 May 2023 | 8 | 7 | 0 |
| 4 Jun 2023 | 6 | 4 | 0 |
| 11 Jun 2023 | 7 | 6 | 0 |
| 18 Jun 2023 | 5 | 5 | 0 |
| 25 Jun 2023 | 6 | 18 | 0 |
| 2 Jul 2023 | 8 | 6 | 0 |
| 9 Jul 2023 | 5 | 5 | 2 |
| 16 Jul 2023 | 3 | 3 | 1 |
| 23 Jul 2023 | 1 | 4 | 0 |
| 30 Jul 2023 | 2 | 4 | 0 |
| 6 Aug 2023 | 5 | 7 | 0 |
| 13 Aug 2023 | 5 | 5 | 0 |
| 20 Aug 2023 | 0 | 4 | 0 |
| 27 Aug 2023 | 4 | 6 | 0 |
| 3 Sep 2023 | 34 | 20 | 0 |
| 10 Sep 2023 | 11 | 22 | 0 |
| 17 Sep 2023 | 37 | 10 | 4 |
| 24 Sep 2023 | 21 | 12 | 10 |
| 1 Oct 2023 | 43 | 13 | 28 |
mRNA
| 21 May 2023 | 20 | 24 |
|---|---|---|
| 28 May 2023 | 25 | 32 |
| 4 Jun 2023 | 15 | 15 |
| 11 Jun 2023 | 18 | 19 |
| 18 Jun 2023 | 17 | 14 |
| 25 Jun 2023 | 16 | 11 |
| 2 Jul 2023 | 20 | 13 |
| 9 Jul 2023 | 16 | 9 |
| 16 Jul 2023 | 17 | 11 |
| 23 Jul 2023 | 15 | 9 |
| 30 Jul 2023 | 16 | 10 |
| 6 Aug 2023 | 16 | 10 |
| 13 Aug 2023 | 20 | 10 |
| 20 Aug 2023 | 16 | 7 |
| 27 Aug 2023 | 38 | 21 |
| 3 Sep 2023 | 57 | 73 |
| 10 Sep 2023 | 40 | 33 |
| 17 Sep 2023 | 83 | 79 |
| 24 Sep 2023 | 78 | 56 |
| 1 Oct 2023 | 90 | 69 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Aug 2023 | 580 |
|---|---|
| Sep 2023 | 379 |
| Oct 2023 | 400 |
| Nov 2023 | 404 |
| Dec 2023 | 331 |
| Jan 2024 | 323 |
| Feb 2024 | 316 |
| Apr 2024 | 314 |
| May 2024 | 312 |
| Jun 2024 | 287 |
| Jul 2024 | 309 |
| Aug 2023 | 3,900 |
|---|---|
| Sep 2023 | 3,900 |
| Oct 2023 | 3,900 |
| Nov 2023 | 3,900 |
| Dec 2023 | 3,900 |
| Jan 2024 | 3,900 |
| Feb 2024 | 3,900 |
| Mar 2024 | 5,600 |
| Apr 2024 | 5,600 |
| May 2024 | 5,600 |
| Jun 2024 | 5,600 |
| Jul 2024 | 5,600 |
Moderna other data
56.69%
-0.01%
of MRNA is owned by hedgeΒ funds
958
-118
244.31M
-1.73M
shares is hold by hedgeΒ funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 55902 |
| Mar 2024 | 0 | 60970 |
| Apr 2024 | 0 | 75705 |
| May 2024 | 0 | 60255 |
| Jun 2024 | 0 | 15000 |
| Jul 2024 | 0 | 75689 |
| Aug 2024 | 0 | 3518 |
| Sep 2024 | 0 | 983 |
| Oct 2024 | 0 | 715 |
| Nov 2024 | 0 | 3406 |
| Dec 2024 | 0 | 955 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | KLINGER SHANNON THYME officer: Chief Legal Officer | Common Stock | 529 | $44.68 | $23,637 | ||
Option | KLINGER SHANNON THYME officer: Chief Legal Officer | Common Stock | 1,138 | N/A | N/A | ||
Option | KLINGER SHANNON THYME officer: Chief Legal Officer | Restricted Stock Units | 1,138 | N/A | N/A | ||
Sale | KLINGER SHANNON THYME officer: Chief Legal Officer | Common Stock | 112 | $43.3 | $4,849 | ||
Sale | HOGE STEPHEN officer: President | Common Stock | 314 | $43.3 | $13,595 | ||
Option | KLINGER SHANNON THYME officer: Chief Legal Officer | Common Stock | 232 | N/A | N/A | ||
Option | KLINGER SHANNON THYME officer: Chief Legal Officer | Restricted Stock Units | 232 | N/A | N/A | ||
Option | HOGE STEPHEN officer: President | Common Stock | 651 | N/A | N/A | ||
Option | HOGE STEPHEN officer: President | Restricted Stock Units | 651 | N/A | N/A | ||
Sale | MOCK JAMES M officer: Chief Fi.. | Common Stock | 1,420 | $42.79 | $60,760 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful
Pfizer Looks Like A Great Play At Current Valuations
Moderna: After A Crash From $500 To $25, I'm Buying This "Call Option" On Pandemics And Cancer
More Downside For Moderna Before The Breakthrough
Moderna: The Good News Isn't Enough
Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Arbutus: Positive Imdusiran Data Leads To Phase 2B Development
Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies
-
What's the price of Moderna stock today?
One share of Moderna stock can currently be purchased for approximately $27.75.
-
When is Moderna's next earnings date?
Unfortunately, Moderna's (MRNA) next earnings date is currently unknown.
-
Does Moderna pay dividends?
No, Moderna does not pay dividends.
-
How much money does Moderna make?
Moderna has a market capitalization of 15.30B and it's past yearsβ income statements indicate that its last revenue has decreased compared to the previous period by 64.45% to 6.85B US dollars.
-
What is Moderna's stock symbol?
Moderna, Inc. is traded on the NASDAQ under the ticker symbol "MRNA".
-
What is Moderna's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Moderna?
Shares of Moderna can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Moderna's key executives?
Moderna's management team includes the following people:
- Mr. Stephane Bancel Chief Executive Officer & Director(age: 52, pay: $3,860,000)
- Dr. Stephen Hoge Pres(age: 49, pay: $1,260,000)
- Mr. Juan Andres Chief Technical Operations & Quality Officer(age: 60, pay: $1,250,000)
- Mr. David W. Meline Chief Financial Officer & Principal Accounting Officer(age: 68, pay: $932,620)
- Dr. Noubar B. Afeyan Ph.D. Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board(age: 62, pay: $107,500)
-
Is Moderna founder-led company?
Yes, Moderna is a company led by its founder Dr. Noubar B. Afeyan Ph.D..
-
How many employees does Moderna have?
As Jul 2024, Moderna employs 5,600 workers.
-
When Moderna went public?
Moderna, Inc. is publicly traded company for more then 6 years since IPO on 7 Dec 2018.
-
What is Moderna's official website?
The official website for Moderna is modernatx.com.
-
Where are Moderna's headquarters?
Moderna is headquartered at 200 Technology Square, Cambridge, MA.
-
How can i contact Moderna?
Moderna's mailing address is 200 Technology Square, Cambridge, MA and company can be reached via phone at +61 77146500.
-
What is Moderna stock forecast & price target?
Based on 10 Wall Street analysts` predicted price targets for Moderna in the last 12 months, the avarage price target is $103.87. The average price target represents a 274.29% change from the last price of $27.75.
Moderna company profile:
Moderna, Inc.
modernatx.comExchange:
NASDAQ
Full time employees:
5,600
Industry:
Biotechnology
Sector:
Healthcare
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
200 Technology Square
Cambridge, MA 02139
Cambridge, MA 02139
CIK: 0001682852
ISIN: US60770K1079
CUSIP: 60770K107
